
B细胞成熟抗原(BCMA)靶向新药开发大盘点 - 知乎
bcma(cd269;tnfrsf17)也是肿瘤坏死因子受体超家族的一员,于20世纪90年代初首次被发现。这种184个氨基酸的糖蛋白在b细胞成熟和分化为浆细胞中起主要作用。
B-cell maturation antigen - Wikipedia
B-cell maturation antigen (BCMA or BCM), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17), is a protein that in humans is encoded by the TNFRSF17 gene. TNFRSF17 is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF). [5][6][7]
B-cell maturation antigen (BCMA) in multiple myeloma: rationale …
2020年2月13日 · B-cell maturation antigen, also referred to as TNFRSF17 or CD269, is a member of the tumor necrosis factor receptor (TNFR) superfamily [6, 7]. Ligands for BCMA include B-cell...
PE anti-human CD269 (BCMA) Antibody - BioLegend
CD269, also known as B cell maturation antigen (BCMA), is a 27 kD, single pass transmembrane protein with one TNFR-Cys repeat on its extracellular domain. CD269 is a B cell maturation factor, essential for the long-term survival of plasma cells.
B细胞成熟抗原BCMA - mabnus.cn
2024年8月20日 · bcma是肿瘤坏死因子受体超家族成员17(tnfrsf17),也称为b细胞成熟抗原(cd269),促进b细胞存活并在调节体液免疫中发挥作用。 BCMA在多发性骨髓瘤(MM)中高表达,BCMA是MM诊断的生物标志物。
新兴治疗靶点BCMA - 知乎 - 知乎专栏
TNFRSF17是TNF-receptor家族的一员,被称为肿瘤坏死因子受体超家族成员17,又名B细胞成熟抗原(BCMA或BCM)或CD269,它是由TNFRSF17基因编码的蛋白质。 该受体表达于B淋巴细胞及浆细胞表面,是一种B淋巴细胞成熟的标…
BD Pharmingen™ PE Mouse Anti-Human BCMA (CD269) - BD …
CD269 (BCMA) functions as a B cell maturation factor that is essential for the survival of long-lived bone marrow plasma cells. A soluble form of CD269 (BCMA) is generated by γ-secretase that can regulate plasma cell survival and differentiation.
针对多发性骨髓瘤的 B 细胞成熟抗原 (BCMA)
作为一种更具选择性的治疗候选抗原,b 细胞成熟抗原 (bcma/tnfrsf17/cd269) 受到了重点关注。 BCMA 是一种属于 TNFR 超家族的跨膜蛋白,并且几乎只在成浆细胞和分化的浆细胞表面表达。
CD269 (BCMA) Antibody, anti-human, REAfinity™ | Miltenyi …
CD269 promotes B cell survival and plays a role in the regulation of humoral immunity. Binding of CD269 to CD257 blocks the binding of CD257 to its receptor on the plasma membrane and inhibits CD257-triggered B lymphocyte costimulation. Overexpression of CD269 activates NF-κB and JNK, and this activation is potentiated by CD257.
带你全面了解靶点BCMA(03) - 知乎专栏
bcma(cd269;tnfrsf17)也是肿瘤坏死因子受体超家族的一员,于20世纪90年代初首次被发现。这种184个氨基酸的糖蛋白在b细胞成熟和分化为浆细胞中起主要作用。